Can this new drug safely reverse a blood thinner? early trial underway
Knowledge-focused
Completed
This early-phase trial tested the safety of a new drug called BB-025, designed to reverse the effects of another experimental drug, BB-031. 72 healthy volunteers received either BB-025 or a placebo, alone or after BB-031, and were monitored for 28 days. The main goal was to check…
Phase: PHASE1 • Sponsor: Basking Biosciences, Inc. • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:04 UTC